FDA Warning Letter — Safrel Pharmaceuticals LLC
The FDA took a Warning Letter action against Safrel Pharmaceuticals LLC on August 12, 2026 (Dayton, NJ). The action was issued by CFSAN and concerns food/cosmetics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Safrel Pharmaceuticals LLC
- Date
- August 12, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Center
- CFSAN
- Location
- Dayton, NJ (United States)